Organon & Co. (OGN)

Organon & Co. Revenue

Organon & Co. had revenue of $1.56B in the quarter ending June 30, 2026, a decrease of -2.26%. This brings the company's total for the last twelve months to $6.13B, down -2.45% year-over-year. In the year 2025, Organon & Co. had annual revenue of $6.22B, down -2.92%. That makes Organon & Co. the 2,241st largest company in the world by revenue and 653rd in the United States.

• Revenue (ttm): $6.13B
• Revenue Growth: -2.45%
• P/S Ratio: 0.59
• Revenue / Employee: $612,700
• Employees: 10,000
• Market Cap: 3.61B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Established Brands 3.69B 59.4%
• Women's Health 1.75B 28.2%
• Biosimilars 691.00M 11.1%
• Other Product Group 82.00M 1.3%

By Geography

Chart

• Europe and Canada 1.62B 26.0%
• United States 1.60B 25.8%
• Latin America, Middle East, Russia and Africa 1.07B 17.2%
• Asia Pacific and Japan 1.00B 16.1%
• China 829.00M 13.3%
• Other International 93.00M 1.5%

Fiscal year ended Dec 31, 2025 See the full Organon & Co. breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.22B	-187.00M	-2.92%
Dec 31, 2024	6.40B	140.00M	2.24%
Dec 31, 2023	6.26B	89.00M	1.44%
Dec 31, 2022	6.17B	-130.00M	-2.06%
Dec 31, 2021	6.30B	-228.00M	-3.49%
Dec 31, 2020	6.53B	-1.25B	-16.01%
Dec 31, 2019	7.78B	-2.00B	-20.46%
Dec 31, 2018	9.78B	-723.00M	-6.89%
Dec 31, 2017	10.50B	-	-

Data Source: Fiscal.ai Last updated: Jul 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error